Verbatim response from Perplexity
Zepbound works better for weight loss, producing significantly greater results than Wegovy in head-to-head trials [1][3]. After 72 weeks, participants on Zepbound lost an average of 20.2% of their body weight (about 50 pounds), compared to 13.7% (about 33 pounds) for those on the 2.4 mg dose of Wegovy [1][6]. This superior performance is due to Zepbound’s dual-action approach, which targets both GLP-1 and GIP hormone receptors, whereas Wegovy targets only GLP-1 [1][2].
Regarding ease of getting online, Wegovy is likely easier to obtain because it comes in both injectable and pill forms, offering greater flexibility for patients [2]. While both medications are available through telehealth services, Wegovy has a longer track record, more established insurance coverage, and is approved for a broader range of patients (including adolescents 12+) [3]. Zepbound is only available as an injection and is newer, which may limit immediate availability or insurance approval compared to Wegovy [2][3].
Recommendation:
- If your primary goal is maximum weight loss, choose Zepbound [3].
- If you need proven cardiovascular risk reduction, are an adolescent, or want pill flexibility, choose Wegovy [3].
- Always check insurance coverage first: if only one is covered, prioritize that option [3][7].
- Consult your doctor to determine which aligns best with your health history and goals [3].